Stimcell Energetics (STME) Net Income Growth (5y) (2021 - 2024)
Stimcell Energetics (STME) Net Income Growth (5y) (2021 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.35 Bn | 175.06 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn |
| 3 | Medtronic | 107.93 Bn | 98.71 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.82 Bn | 66.37 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.03 Bn | 44.36 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.90 Bn | 25.62 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.96 Bn | 20.83 Bn | 2.07 Bn |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | 36.32% |
| Feb 29, 2024 | -19.30% |
| Nov 30, 2023 | -20.07% |
| Aug 31, 2023 | -18.35% |
| May 31, 2022 | -19.79% |
| Feb 28, 2022 | 16.57% |
| Nov 30, 2021 | 6.58% |
| Aug 31, 2021 | 2.57% |
| May 31, 2021 | 10.63% |
| Feb 28, 2021 | 9.57% |